Microbiome Center Utrecht

Our intestinal tract, skin and upper respiratory tract among other body sites are routinely exposed and colonized by numerous and various bacteria impacting our health. At the Microbiome Center Utrecht, we aim to explore the interactions between these microbes and our human host cells with the aim of being able to predict and prevent diseases, as well as paving the way to innovative therapeutic approaches.  To achieve this, we make use of technology such as 16S rRNA profiling, metagenomic and meta-transcriptomic sequencing, anaerobic microbiota culturomics, in vitro and in vivo disease models, tissue culture, and organoids.

Collaborate with us!

The Microbiome Center Utrecht provides a variety of microbiome profiling options and analysis to clinical research groups both within and outside UMC Utrecht. Are you interested in collaborating with us? Please contact:

Janetta Top

j.top@umcutrecht.nl

Overview of collaborations and output

Julius Center for Health Sciences and Primary Care                          Prof. Janneke van de Wijgert

Nasopharyngeal microbiome composition by SARS-CoV-2 presence and severity, 2025, https://pubmed.ncbi.nlm.nih.gov/40603926/

Urinary tract infections in postmenopausal women revisited (UTIr): a prospective observational cohort study to explore the urobiomes of postmenopausal women with and without recurrent urinary tract infections, 2025, https://pubmed.ncbi.nlm.nih.gov/40596882/ 

The endometrial microbiota of women with or without a live birth within 12 months after a first failed IVF/ICSI cycle, 2023, https://pubmed.ncbi.nlm.nih.gov/36859567/ 

Department of Rheumatology and Clinical Immunology                    Helen Leavis

Gut microbial dysbiosis, IgA, and Enterococcus in common variable immunodeficiency with immune dysregulation, https://pubmed.ncbi.nlm.nih.gov/39819634/

Department of Medical Oncology                                               Prof. Karijn Suijkerbuijk

Gut microbiome and immune checkpoint inhibitor toxicity, 2025, https://pubmed.ncbi.nlm.nih.gov/39793444/

Princess Máxima Center for Pediatric Oncology                                    Dr. Jasper van der Lugt and Dr. Raoull Hoogendijk

Omnigene-Guttm ensures fecal microbiome stability in the pediatric population, 2024, https://pubmed.ncbi.nlm.nih.gov/39641864/